Biomarin Pharmaceutical (BMRN) Times Interest Earned (2009 - 2026)
Biomarin Pharmaceutical's (BMRN) Times Interest Earned was 1.75 for Q2 2026, down 98.3% from 103.35 a year earlier and down 79.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Times Interest Earned (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's Times Interest Earned came in at 1.79, down 97.4% year-over-year; for FY2025, it came in at 37.57, down 1.7% from FY2024.
- By year, Times Interest Earned came in at 38.23 in FY2024 (+256.7%), 10.72 in FY2023 (+6.3%), 10.08 in FY2022 and -5.37 in FY2021.
- Five-year quarterly Times Interest Earned spans a low of -18.10 in Q3 2025 and a high of 103.35 in Q2 2025.
- Year over year, Times Interest Earned gained in three of the last five quarters, with growth averaging 121.6%.
- The high point for year-over-year Times Interest Earned in five years was Q1 2022 (growth of 447.1%); the low point was Q2 2026 (a decline of 98.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 8.67 (Q1 2026), -16.06 (Q4 2025) and -18.10 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 1.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 |
| Mar 31, 2026 | 8.67 |
| Dec 31, 2025 | -16.06 |
| Sep 30, 2025 | -18.10 |
| Jun 30, 2025 | 103.35 |
| Mar 31, 2025 | 78.20 |
| Dec 31, 2024 | 62.63 |
| Sep 30, 2024 | 38.37 |
| Jun 30, 2024 | 33.70 |
| Mar 31, 2024 | 24.94 |
| Dec 31, 2023 | 4.47 |
| Sep 30, 2023 | 8.08 |
| Jun 30, 2023 | 17.46 |
| Mar 31, 2023 | 16.85 |
| Dec 31, 2022 | -3.61 |
| Sep 30, 2022 | -0.52 |
| Jun 30, 2022 | 10.15 |
| Mar 31, 2022 | 36.08 |
| Dec 31, 2021 | -17.13 |
| Sep 30, 2021 | -13.75 |
API Access
Biomarin Pharmaceutical Times Interest Earned API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=times-interest-earned&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "times-interest-earned", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=times-interest-earned&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();